FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kota Iwahori

Research Profile

Chemicals & Drugs

Procedures

Anatomy

Tumor Cell Line

Physiology

Disorders

Living Beings

Concepts & Ideas

Co-author Network

Publications

TOP 3
Takuhei Yokoyama; Kiyoshi Yoshino; Satoshi Serada; Yutaka Ueda; Takayuki Enomoto; Minoru Fujimoto; Masami Fujita; Kota Iwahori; Tadashi Kimura; Satoru Kyo; Shinya Matsuzaki; Akiko Morimoto; Tetsuji Naka
Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.
Kota Iwahori; Ichiro Kawase; Tadamitsu Kishimoto; Hiroyuki Mizuguchi; Shintaro Nomura; Barry Ripley; Satoshi Serada; Kazuki Shimada; Tsuyoshi Takahashi; Minoru Fujimoto; Tetsuji Naka
SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
Yoshihito Souma; Tsuyoshi Takahashi; Yuichiro Doki; Minoru Fujimoto; Kota Iwahori; Yasuaki Miyazaki; Masaki Mori; Kiyokazu Nakajima; Toshirou Nishida; Barry Ripley; Yoshiki Sawa; Satoshi Serada; Tetsuji Naka
Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kota Iwahori (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Takuhei Yokoyama; Kiyoshi Yoshino; Satoshi Serada; Yutaka Ueda; Takayuki Enomoto; Minoru Fujimoto; Masami Fujita; Kota Iwahori; Tadashi Kimura; Satoru Kyo; Shinya Matsuzaki; Akiko Morimoto; Tetsuji Naka
Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.
International journal of cancer. Journal international du cancer 2013;132(2):472-84.
2013: Kota Iwahori; Ichiro Kawase; Tadamitsu Kishimoto; Hiroyuki Mizuguchi; Shintaro Nomura; Barry Ripley; Satoshi Serada; Kazuki Shimada; Tsuyoshi Takahashi; Minoru Fujimoto; Tetsuji Naka
SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
International journal of cancer. Journal international du cancer 2013;132(2):459-71.
2012: Yoshihito Souma; Tsuyoshi Takahashi; Yuichiro Doki; Minoru Fujimoto; Kota Iwahori; Yasuaki Miyazaki; Masaki Mori; Kiyokazu Nakajima; Toshirou Nishida; Barry Ripley; Yoshiki Sawa; Satoshi Serada; Tetsuji Naka
Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells.
International journal of cancer. Journal international du cancer 2012;131(6):1287-96.
2012: Kota Iwahori; Ichiro Kawase; Yoshiro Kishi; Masashi Kobayashi; Yoshihiro Fujii; Tomonori Hirashima; Norio Okamoto; Hidekazu Suzuki; Rie Uehara; Tetsuji Naka
Serum HE4 as a diagnostic and prognostic marker for lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(4):1141-9.
2011: Kota Iwahori; Ichiro Kawase; Tadamitsu Kishimoto; Chun Man Lee; Hiroyuki Mizuguchi; Shintaro Nomura; Meinoshin Okumura; Tadashi Osaki; Barry Ripley; Satoshi Serada; Tsuyoshi Takahashi; Minoru Fujimoto; Tetsuji Naka
Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma.
International journal of cancer. Journal international du cancer 2011;129(4):1005-17.
2008: Kota Iwahori; Tadashi Osaki; Satoshi Serada; Minoru Fujimoto; Hidekazu Suzuki; Yoshiro Kishi; Akihito Yokoyama; Hironobu Hamada; Yoshihiro Fujii; Kentaro Yamaguchi; Tomonori Hirashima; Kaoru Matsui; Isao Tachibana; Yusuke Nakamura; Ichiro Kawase; Tetsuji Naka
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin.
Lung cancer (Amsterdam, Netherlands) 2008;62(1):45-54.
2006: Yoshitaka Ogata; Tadashi Osaki; Tetsuji Naka; Kota Iwahori; Mitsugi Furukawa; Izumi Nagatomo; Takashi Kijima; Toru Kumagai; Mitsuhiro Yoshida; Isao Tachibana; Ichiro Kawase
Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation.
Neoplasia (New York, N.Y.) 2006;8(10):817-25.
2002: Yoshikazu Nakaoka; Kota Iwahori; Keita Kunisada; Yasushi Fujio; Masahiro Izumi; Tomoaki Osugi; Yuichi Oshima; Hisao Hirota; Keiko Yamauchi-Takihara
A case of hypereosinophilic syndrome presenting mid-ventricular obstruction.
Heart and vessels 2002;16(3):121-4.
2000: Atsushi Kumanogoh; Chie Watanabe; I Lee; X Wang; Wei Shi; H Araki; H Hirata; Kota Iwahori; Junji Uchida; Teruhito Yasui; Makoto Matsumoto; Kanji Yoshida; Hidetaka Yakura; C Pan; Jane R Parnes; Hitoshi Kikutani
Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.
Immunity 2000;13(5):621-31.